The authors showed that the exposure of human colorectal cancer cells to OX led to a marked induction of VEGF and concluded, that the neutralization of pro-survival responses with anti-VEGF therapy might explain some of the beneficial effects of anti-VEGF therapy when added to chemotherapy [48]. Here, VEGFA is linked to colorectal cancer.